Latest news
IDEAYA Biosciences (NASDAQ:IDYA) Is In A Strong Position To Grow Its Business - MoomooMoomoo · Thu, 06 Aug 2026 15:40:14 GMTThe Bull Case For IDEAYA Biosciences (IDYA) Could Change Following Wider Loss And New Roche Partnership - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 20:12:41 GMTIDEAYA Biosciences (NASDAQ: IDYA) reports $1.24B cash and rising R&D spend - Stock TitanStock Titan · Tue, 04 Aug 2026 20:07:45 GMTUveal melanoma trial reports 6.9 months progression-free vs. 3.1 - Stock TitanStock Titan · Tue, 04 Aug 2026 10:00:00 GMTWill IDEAYA’s (IDYA) IDE892 Combo Strategy in MTAP‑Deleted Cancers Reshape Its Targeted Oncology Narrative? - simplywall.stsimplywall.st · Thu, 30 Jul 2026 03:34:56 GMTIDEAYA Biosciences (IDYA) Advances IDE892 Trial, Is The Upside Already Priced In? - simplywall.stsimplywall.st · Tue, 28 Jul 2026 07:00:00 GMT